Loading insider details...
Beta
Latest Form 4 (Apr 2, 2026): Grant/Award of 75,000 SKYE shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Apr 2, 2026 | Skye Bioscience, Inc. (SKYE) | Grant/Award | 75,000 | n/a |
| Feb 27, 2026 | Mereo BioPharma Group plc (MREO) | Grant/Award | 66,000 | n/a |
| Feb 10, 2026 | Skye Bioscience, Inc. (SKYE) | Grant/Award | 35,000 | n/a |
| Jun 13, 2025 | COMPASS Pathways plc (CMPS) | Grant/Award | 26,000 | n/a |
| Feb 26, 2025 | Skye Bioscience, Inc. (SKYE) | Grant/Award | 35,000 | n/a |
| Feb 6, 2025 | Mereo BioPharma Group plc (MREO) | Grant/Award | 55,000 | n/a |
| Oct 31, 2024 | Skye Bioscience, Inc. (SKYE) | Grant/Award | 70,000 | n/a |
| Aug 5, 2024 | COMPASS Pathways plc (CMPS) | Tax Withholding | 161 | $1.1K |
| May 13, 2024 | COMPASS Pathways plc (CMPS) | Grant/Award | 26,000 | n/a |
| May 3, 2024 | COMPASS Pathways plc (CMPS) | Tax Withholding | 211 | $1.8K |